Establishes NJ Water Supply and Pharmaceutical Product Study Commission.
Impact
The bill is expected to provide a structured approach to addressing the potential risks associated with pharmaceutical products in water supplies. By forming this commission, the New Jersey Legislature aims to conduct comprehensive studies that could lead to regulatory changes, thereby improving public health and bolstering public confidence in drinking water safety. Additionally, the research outcomes might lay the groundwork for establishing proper guidelines for the detection and management of pharmaceutical contaminants.
Summary
Senate Bill S2236 aims to establish the New Jersey Water Supply and Pharmaceutical Product Study Commission, which will focus on the investigation and evaluation of pharmaceutical contaminants present in the state's water supply. The bill acknowledges increasing concerns over pharmaceutical products such as antibiotics, hormones, and anti-depressants, being detected in water systems across the country. It emphasizes the need for further research into the potential health impacts of these pharmaceutical substances on both human health and the environment.
Contention
Notable points of contention surrounding S2236 may arise from concerns regarding the adequacy of the commission's authority and the effectiveness of any resulting recommendations. Critics may question whether the commission, by nature, can adequately tackle the complexities of pharmaceutical contamination in water supplies, particularly given the existing absence of robust governmental guidelines in this area. Furthermore, stakeholders might debate the financial implications of implementing any new regulatory measures that emerge from the commission's findings, considering the significant investment that may require to ensure public health.
Amends the types of products which pharmacists may prescribe as substitute drugs or products to include "devices and supplies" and "therapeutically equivalent drugs and pharmaceuticals".
Amends the types of products which pharmacists may prescribe as substitute drugs or products to include "devices and supplies" and "therapeutically equivalent drugs and pharmaceuticals."
Permits certain winery license holders to sell wine produced by other winery licensees under certain circumstances; establishes supplemental wine production facility license.
Providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; establishing the Pharmaceutical Transparency Review Fund; and imposing a penalty.
An Act to amend and reenact ยงยง 4.1-1600, 4.1-1602, and 4.1-1603 of the Code of Virginia, relating to medical cannabis program; product labels; delivery.